Related Experiment Video
Updated: Aug 5, 2026
08:11
Ecotoxicological Effects of Microplastics on Bird Embryo Development by Hatching without Eggshell
Published on: August 14, 2021
The Reproductive Toxicity of Microplastics: From Environmental Contamination to Organ Distribution and Reproductive
Shubhradeep Chakraborty1, Abhratanu Ganguly1, Satadal Adhikary2
1Toxicology Research Laboratory, Department of Animal Science, Kazi Nazrul University, Asansol, West Bengal, India.
Environmental Toxicology
|July 30, 2026
Summary
Microplastics (MPs) contaminate the environment and human bodies, accumulating in reproductive tissues. These tiny plastic particles may harm reproductive health by disrupting hormones, causing inflammation, and damaging cells.
Area of Science:
- Environmental Science
- Toxicology
- Reproductive Biology
Background:
- Microplastics (MPs) are pervasive environmental contaminants found in air, water, soil, food, and drinking water.
- MPs have been detected in human reproductive tissues, including ovarian follicular fluid, uterine tube, semen, and testicular tissue.
Purpose of the Study:
- To critically review current data on the environmental distribution, human exposure, and accumulation of MPs in reproductive systems.
- To discuss the mechanisms of MP-induced reproductive toxicity, including oxidative stress, endocrine disruption, inflammation, and apoptosis.
Main Methods:
- Comprehensive literature review of recent studies on microplastic distribution and toxicity.
- Analysis of data on MP levels in human reproductive samples.
- Examination of molecular pathways involved in MP-induced reproductive harm.
Main Results:
- MPs are widely distributed and enter the human body, with documented presence in reproductive organs.
- Evidence suggests MPs adversely affect gamete development and maturation.
- Mechanisms include modulation of hormonal pathways, induction of oxidative stress and inflammation, and promotion of germ cell pyroptosis.
Conclusions:
- MPs pose a potential risk to reproductive health through various toxicological pathways.
- Further toxicological evaluations and epidemiological studies are crucial to fully assess risks.
- Knowledge gaps remain regarding the precise mechanistic pathways of MP-induced reproductive toxicity.
More Related Videos
Related Concept Videos
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:28Microbial Bioremediation of Pesticides
Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...